In the latest fiscal period Q1'27, total operating expenses reached a high of 521M USD. This comprised 200.4M USD in R&D Expenses and 320.6M USD in SG&A Expenses, reflecting the company's largest quarterly expenditure within the reported timeframe. From Q2'24 to Q1'27, the data reveals a consistent upward trend in total operating costs, growing from 367.5M USD to 521M USD. SG&A Expenses remained the dominant cost driver throughout the period, while R&D Expenses showed steady growth with a notable acceleration starting in Q1'26. Despite minor fluctuations in SG&A during FY2025, both segments reached their peak levels by Q1'27, signaling an ongoing expansion in operational investment.